These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31299410)

  • 1. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia.
    Aliberti S; Cook GS; Babu BL; Reyes LF; H Rodriguez A; Sanz F; Soni NJ; Anzueto A; Faverio P; Sadud RF; Muhammad I; Prat C; Vendrell E; Neves J; Kaimakamis E; Feneley A; Swarnakar R; Franzetti F; Carugati M; Morosi M; Monge E; Restrepo MI;
    J Infect; 2019 Oct; 79(4):300-311. PubMed ID: 31299410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.
    Jenkins TC; Sakai J; Knepper BC; Swartwood CJ; Haukoos JS; Long JA; Price CS; Burman WJ
    Acad Emerg Med; 2012 Jun; 19(6):703-6. PubMed ID: 22632455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
    Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
    Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant Streptococcus pneumoniae.
    Campbell GD; Silberman R
    Clin Infect Dis; 1998 May; 26(5):1188-95. PubMed ID: 9597251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia.
    Jones RN; Jacobs MR; Sader HS
    Int J Antimicrob Agents; 2010 Sep; 36(3):197-204. PubMed ID: 20558045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of azithromycin in the treatment of community-acquired pneumonia, including patients with macrolide-resistant Streptococcus pneumoniae infection.
    Yanagihara K; Izumikawa K; Higa F; Tateyama M; Tokimatsu I; Hiramatsu K; Fujita J; Kadota J; Kohno S
    Intern Med; 2009; 48(7):527-35. PubMed ID: 19336954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug treatment of pneumococcal pneumonia in the elderly.
    Neralla S; Meyer KC
    Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study.
    Carugati M; Aliberti S; Sotgiu G; Blasi F; Gori A; Menendez R; Encheva M; Gallego M; Leuschner P; Ruiz-Buitrago S; Battaglia S; Fantini R; Pascual-Guardia S; Marin-Corral J; Restrepo MI;
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1513-1525. PubMed ID: 32242314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel.
    Regev-Yochay G; Chowers M; Chazan B; Gonzalez E; Gray S; Zhang Z; Pride M
    Hum Vaccin Immunother; 2018; 14(10):2527-2532. PubMed ID: 30188760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal community-acquired pneumonia in 148 hospitalized adult patients.
    Porath A; Schlaeffer F; Pick N; Leinonen M; Lieberman D
    Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):863-70. PubMed ID: 9495665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzanów County, Poland, 2010 to 2012.
    Harat R; Alexander R; Gray S; Gutterman EM; Pluta J; Pride M; Shite S; Fijolek J; Kozub J
    Pneumonol Alergol Pol; 2016; 84(2):95-103. PubMed ID: 27238167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and microbiological characteristics of community-acquired pneumonia associated with Streptococcus pneumoniae in adult patients in Mexico.
    Echaniz-Aviles G; Garza-González E; Román-Mancha AL; Morfín-Otero R; Rodríguez-Noriega E; Ayala-Gaytán JJ; Guajardo-Lara CE; Soto-Nogueron A; Carnalla-Barajas MN; Camacho-Ortiz A
    Rev Argent Microbiol; 2019; 51(3):234-240. PubMed ID: 30635204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.
    Takeuchi N; Naito S; Ohkusu M; Abe K; Shizuno K; Takahashi Y; Omata Y; Nakazawa T; Takeshita K; Hishiki H; Hoshino T; Sato Y; Ishiwada N
    Epidemiol Infect; 2020 Apr; 148():e91. PubMed ID: 32299523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology Characteristics of
    Zhao W; Pan F; Wang B; Wang C; Sun Y; Zhang T; Shi Y; Zhang H
    Front Cell Infect Microbiol; 2019; 9():258. PubMed ID: 31380301
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program.
    Gotfried MH
    Am J Med; 2001 Dec; 111 Suppl 9A():25S-29S; discussion 36S-38S. PubMed ID: 11755440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern.
    File TM
    Am J Med; 2004 Aug; 117 Suppl 3A(3):39S-50S. PubMed ID: 15360096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.